z-logo
open-access-imgOpen Access
Affinity-Based Drug Delivery Systems for Tissue Repair and Regeneration
Author(s) -
Katarina Vulic,
Molly S. Shoichet
Publication year - 2014
Publication title -
biomacromolecules
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.689
H-Index - 220
eISSN - 1526-4602
pISSN - 1525-7797
DOI - 10.1021/bm501084u
Subject(s) - drug delivery , regeneration (biology) , controlled release , chemistry , biophysics , microbiology and biotechnology , computational biology , biology , pharmacology , organic chemistry
Affinity-based release systems use transient interactions to sustain and control the release of a therapeutic from a polymeric matrix. The most common affinity-based systems use heparin-based scaffolds to sustain the release of heparin-binding proteins, such as fibroblast growth factor-2 (FGF2) and vascular endothelial growth factor (VEGF). However, novel affinity-based systems based on, for example, protein-protein or DNA-protein interactions, are emerging to control the release of an expanding repertoire of therapeutics. Mathematical models of affinity-based systems have provided a thorough understanding of which parameters affect release rate from these systems, and how these release rates can be tuned. In this review, recent affinity-based release systems will be described, including an overview of the various types of affinity interactions used to modulate release, the mechanisms by which release from these systems is tuned, and the time scales of sustained release. This advanced drug delivery paradigm provides tunable and predictable release rates and has expanded the scope of deliverable therapeutics for tissue repair and regeneration.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here